stars 1 stars 2 stars 3

SaudiVax is a Saudi company whose objectives are to localize biomanufacturing in Saudi Arabia and to increase the reliable supply of high-quality vaccines and biologics for the region. SaudiVax was formed to ensure national health security by supporting the region’s pandemic preparedness against infectious diseases. Furthermore, SaudiVax is nationalizing the industry and is employing highly educated and talented Saudi scientists in alignment with SaudiVision2030. SaudiVax is a unique local developer and manufacturer of high-demand biologic products for Saudi Arabia and beyond. With three business segments, SaudiVax operates as a unique developer and manufacturer of high-demand biologic products. The Advisory business offers expert consulting services to support the development of biotech industries in the region. The Innovation business focuses on late-stage research and development of biologics and vaccines, emphasizing innovation and collaboration. The Manufacturing business utilizes cutting-edge technologies and equipment to produce vaccines and biologics.

SaudiVax Questions

The SaudiVax annual revenue was $2 million in 2026.

Yasser Alkhomri is the Director of Manufacturing Operations of SaudiVax.

18 people are employed at SaudiVax.

SaudiVax is based in Riyadh, Ar Riyad.

The NAICS codes for SaudiVax are [32541, 325, 3254, 32].

The SIC codes for SaudiVax are [28, 283].

Top SaudiVax Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users